In-hospital outcomes associated with renin-angiotensin system inhibitors, Beta-blockers, and mineralocorticoid receptor antagonists in acute decompensated heart failure: Analysis by chronic kidney disease status and heart failure subtypes
In-hospital outcomes associated with renin-angiotensin system inhibitors, Beta-blockers, and mineralocorticoid receptor antagonists in acute decompensated heart failure: Analysis by chronic kidney disease status and heart failure subtypes. // American Heart Journal Plus: Cardiology Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2666602226003071?dgcid=rss_sd_all
In-hospital outcomes associated with renin-angiotensin system inhibitors, Beta-blockers, and mineralocorticoid receptor antagonists in acute decompensated heart failure: Analysis by chronic kidney disease status and heart failure subtypes. American Heart Journal Plus: Cardiology Research and Practice. https://www.sciencedirect.com/science/article/pii/S2666602226003071?dgcid=rss_sd_all
“In-hospital outcomes associated with renin-angiotensin system inhibitors, Beta-blockers, and mineralocorticoid receptor antagonists in acute decompensated heart failure: Analysis by chronic kidney disease status and heart failure subtypes.” American Heart Journal Plus: Cardiology Research and Practice.
@article{article34224,
title = {In-hospital outcomes associated with renin-angiotensin system inhibitors, Beta-blockers, and mineralocorticoid receptor antagonists in acute decompensated heart failure: Analysis by chronic kidney disease status and heart failure subtypes},
journal = {American Heart Journal Plus: Cardiology Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2666602226003071?dgcid=rss_sd_all}
}